| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.03 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |